Atıf Formatları
COVID-19 Vaccinations: Summary Guidance for Cancer Patients in 28 Languages: Breaking Barriers to Cancer Patient Information
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

D. Mauri Et Al. , "COVID-19 Vaccinations: Summary Guidance for Cancer Patients in 28 Languages: Breaking Barriers to Cancer Patient Information," Reviews on Recent Clinical Trials , vol.17, no.1, pp.11-14, 2022

Mauri, D. Et Al. 2022. COVID-19 Vaccinations: Summary Guidance for Cancer Patients in 28 Languages: Breaking Barriers to Cancer Patient Information. Reviews on Recent Clinical Trials , vol.17, no.1 , 11-14.

Mauri, D., Kamposioras, K., Tsali, L., Dambrosio, M., De Bari, B., Hindi, N., ... Salembier, C.(2022). COVID-19 Vaccinations: Summary Guidance for Cancer Patients in 28 Languages: Breaking Barriers to Cancer Patient Information. Reviews on Recent Clinical Trials , vol.17, no.1, 11-14.

Mauri, Davide Et Al. "COVID-19 Vaccinations: Summary Guidance for Cancer Patients in 28 Languages: Breaking Barriers to Cancer Patient Information," Reviews on Recent Clinical Trials , vol.17, no.1, 11-14, 2022

Mauri, Davide Et Al. "COVID-19 Vaccinations: Summary Guidance for Cancer Patients in 28 Languages: Breaking Barriers to Cancer Patient Information." Reviews on Recent Clinical Trials , vol.17, no.1, pp.11-14, 2022

Mauri, D. Et Al. (2022) . "COVID-19 Vaccinations: Summary Guidance for Cancer Patients in 28 Languages: Breaking Barriers to Cancer Patient Information." Reviews on Recent Clinical Trials , vol.17, no.1, pp.11-14.

@article{article, author={Davide Mauri Et Al. }, title={COVID-19 Vaccinations: Summary Guidance for Cancer Patients in 28 Languages: Breaking Barriers to Cancer Patient Information}, journal={Reviews on Recent Clinical Trials}, year=2022, pages={11-14} }